HLN - Haleon plc - Stock Price & Dividends

Exchange: USA Stocks • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: US4055521003

Toothpaste, Vitamins, Pain Relievers, Antacids, Cold Medicines

Haleon plc is a leading consumer healthcare company that develops, manufactures, and sells a wide range of products to improve people's health and wellbeing. With a presence in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific, the company reaches millions of customers worldwide.

One of the key areas of focus for Haleon is oral health. The company offers a variety of products under popular brands such as Sensodyne, Polident, Parodontax, and Biotene, including toothpastes, mouthwashes, and denture care products. These products are designed to promote healthy teeth and gums, and to provide relief from oral health issues such as sensitivity and dry mouth.

In addition to oral health, Haleon also offers a range of vitamins, minerals, and supplements under brands like Centrum, Emergen-C, and Caltrate. These products are designed to support overall health and wellbeing, and to help fill nutritional gaps in people's diets.

Haleon's portfolio also includes a wide range of over-the-counter (OTC) products to treat various health issues. For example, the company offers nasal drops and cold, flu, and allergy relief products under brands like Otrivine, Theraflu, and Flonase. It also provides anti-inflammatory and pain relief products under brands like Voltaren, Panadol, and Advil, as well as antacids and antihistamine products under brands like TUMS, ENO, and Fenistil. These products are designed to provide fast and effective relief from a range of common health issues.

Haleon plc has a rich history, dating back to 1715. The company was previously known as DRVW 2022 plc, but changed its name to Haleon plc in February 2022. Today, the company is headquartered in Weybridge, the United Kingdom, and operates globally. For more information, visit their website at https://www.haleon.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for HLN - Haleon plc  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for HLN - Haleon plc  - Stock Price & Dividends

HLN Stock Overview

Market Cap in USD 40,684m
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
GiC SubIndustry Biotechnology
TER 0.00%
IPO / Inception 2022-07-22

HLN Stock Ratings

Growth 5y 42.0
Fundamental 9.50
Dividend 32.9
Rel. Performance vs Sector -0.17
Analysts 4.00/5
Fair Price Momentum 8.56 USD
Fair Price DCF 8.01 USD

HLN Dividends

Dividend Yield 12m 1.67%
Yield on Cost 5y 2.04%
Dividends CAGR 5y 0.00%
Payout Consistency 100.0%

HLN Growth Ratios

Growth 12m 2.02%
Growth Correlation 12m 32%
Growth Correlation 3m 44%
CAGR 5y 10.32%
CAGR/Mean DD 5y 1.45
Sharpe Ratio 12m -0.17
Alpha vs SP500 12m -5.60
Beta vs SP500 5y weekly 0.13
ValueRay RSI 91.04
Volatility GJR Garch 1y 19.57%
Price / SMA 50 4.95%
Price / SMA 200 7.48%
Current Volume 1704.2k
Average Volume 20d 3442.4k

External Links for HLN Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of HLN stocks?
As of July 21, 2024, the stock is trading at USD 8.91 with a total of 1,704,176 shares traded.
Over the past week, the price has changed by +0.11%, over one month by +4.58%, over three months by +8.39% and over the past year by +4.13%.
What are the forecast for HLN stock price target?
According to ValueRays Forecast Model, HLN Haleon plc will be worth about 9.3 in July 2025. The stock is currently trading at 8.91. This means that the stock has a potential upside of +3.82%.
Issuer Forecast Upside
Wallstreet Target Price 9.9 10.8
Analysts Target Price 9.3 3.82
ValueRay Target Price 9.3 3.82